Risk Stratification of Myelodysplastic Syndromes - Is There Room for Improvement?

被引：0

作者：

Marques, Barbara Almeida ^{[1
,2
,3
,4
,5
]}

Silva, Duarte Pacheco ^{[5
]}

Santos, Joao Gaiao ^{[5
]}

Moura, Pedro Pinho ^{[5
]}

Ana Teresa Simoes, Catia Almeida ^{[5
]}

Oliveira, Ana Catarina ^{[5
]}

Coucelo, Margarida ^{[5
]}

Cortesao, Emilia ^{[1
,2
,6
,7
,8
]}

Geraldes, Catarina ^{[1
,2
,4
,5
,7
,8
]}

机构：

[1] Univ Coimbra, Lab Oncobiol & Hematol, Fac Med, Coimbra, Portugal

[2] Univ Coimbra, Univ Clin Hematol, Fac Med, Coimbra, Portugal

[3] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Res Grp Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal

[4] Ctr Innovat Biomed & Biotechnol CIBB, Coimbra, Portugal

[5] Ctr Hosp & Univ Coimbra, Clin Hematol Dept, Coimbra, Portugal

[6] Ctr Hosp & Univ Coimbra, Coimbra, Portugal

[7] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Area Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal

[8] Clin Acad Ctr Coimbra, Coimbra, Portugal

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-169960

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：12319 / 12320

页数：2

共 50 条

[1] Myelodysplastic Syndromes Classification and Risk Stratification
Komrokji, Rami S.
Zhang, Ling
Bennett, John M.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 443 - +
[2] Updates in Risk Stratification in Myelodysplastic Syndromes
Aguirre, Luis E.
Sallman, David A.
Stone, Richard
Komrokji, Rami S.
CANCER JOURNAL, 2023, 29 (03): : 138 - 142
[3] Editorial: Risk-stratification in myelodysplastic syndromes
Breccia, Massimo
Vinchi, Francesca
Bonifacio, Massimiliano
Binotto, Gianni
Zheng, Gang
FRONTIERS IN ONCOLOGY, 2022, 12
[4] Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet?
Pardanani, Animesh
Tefferi, Ayalew
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2703 - 2704
[5] Current state of prognostication and risk stratification in myelodysplastic syndromes
Zeidan, Amer M.
Gore, Steven D.
Padron, Eric
Komrokji, Rami S.
CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 146 - 154
[6] The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes
DeZern, Amy E.
Greenberg, Peter L.
BLOOD, 2023, 142 (26) : 2258 - 2267
[7] Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes
Mies, Anna
Bozic, Tanja
Kramer, Michael
Franzen, Julia
Ehninger, Gerhard
Bornhauser, Martin
Platzbecker, Uwe
Wagner, Wolfgang
BLOOD, 2016, 128 (22)
[8] Risk stratification in therapy-related myelodysplastic syndromes
Zeidan, Amer M.
ONCOTARGET, 2017, 8 (46) : 80103 - 80104
[9] Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
Garcia-Manero, Guillermo
Chien, Kelly S.
Montalban-Bravo, Guillermo
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (11) : 1399 - 1420
[10] Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?
Zeidan, Amer M.
Prebet, Thomas
Aldin, Ehab Saad
Gore, Steven David
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 191 - 194

← 1 2 3 4 5 →